Customizing Your Glucose Alert & Sound Settings
The Eversense E3 CGM System is designed to provide ON-BODY VIBRATION alerts through your smart transmitter and AUDIO notifications plus VISUAL alerts on your mobile device when your glucose level has reached the alert levels you set.
These are the glucose levels at which you would like the system to alert you if reached.
Low Glucose Alert setting is Always ON.
High Glucose Alert setting can be turned ON and OFF. If turned OFF, there will be no smart transmitter on-body vibration alerts or phone auditory alerts.
These are the glucose levels you would like to remain between.
Both Low and High Glucose Targets are Always ON (cannot be turned OFF).
|
Alert |
Smart Trans |
Mobile Phone |
|
Low Glucose Alert |
3 short vibes x 3 |
Message appears in yellow |
|
High Glucose Alert |
1 long vibe then 2 short vibes |
Message appears in yellow |
Hear the Alerts You Choose: Tap Menu > Settings > Sound Settings
These are the glucose levels at which you would like the system to alert you if reached.
Low Glucose Alert setting is Always ON.
High Glucose Alert setting can be turned ON and OFF. If turned OFF, there will be no smart transmitter on-body vibration alerts or phone auditory alerts.
These are the glucose levels you would like to remain between.
Both Low and High Glucose Targets are Always ON (cannot be turned OFF).
Discuss your settings with your health care provider, if you are not sure where to start, and get the most out of your Eversense E3 CGM System.
Take a step-by-step approach starting from the most basic ones like the low and high glucose alerts and targets, knowing there are alerts that you can add to your routine at a later stage. This might help you get the most out of your Eversense E3 CGM System.
The Apple Watch is a secondary display of Eversense E3 CGM data. Any alerts or notifications received on the Apple Watch should be confirmed on the Eversense CGM Mobile App.
When turned on, the Low and Out of Range Low Glucose alerts will be played at your phone's maximum volume. This allows you to still receive Low and Out of Range Low Glucose alerts on your phone, even if your phone's Silent Mode is on, or Do Not Disturb is on. Read more in Eversense E3 User Guide.
Stay in the know with the Eversense E3 and get helpful pointers on how to manage your diabetes wi...
Learn how to set up and calibrate your system to start getting your glucose data and the most acc...
Find out how the Eversense E3 Smart Transmitter is designed to work the way you need and to be wo...
Trend Arrows And Treatment Decisions >
Stay on top of your diabetes management knowing you get exceptionally accurate1 readings, even wi...
Access your In-App Reports in the Eversense App to better understand your glucose patterns and hi...
Low And High Alerts, And Targets >
The Eversense E3 CGM System is designed to provide ON-BODY VIBRATION alerts through your smart tr...
Predictive And Rate of Change Alerts >
Even with the best management plan, diabetes can still be unpredictable at times. In addition to ...
Keep tabs on your glucose levels over time and share this information, to help you and your healt...
E3 Long Term Exceptional Accuracy >
There is no other CGM system available today to offer such exceptional accuracy with a single sen...
Taking care of family and friends, performing at work each day, challenging yourself with sports,...
When getting ready for traveling with diabetes, there is so much to think of, isn’t it? Of ...
Get Ready For Your Next E3 Sensor >
Preparing for your next sensor in advance will ensure a smooth and uninterrupted experience.
The Eversense® E3 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to 180 days in persons with diabetes age 18 and older. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are still required for calibration primarily one time a day after day 21, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense E3 CGM System is a prescription device; patients should talk to their health care provider to learn more.
The Eversense® 365 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to one year in people (18 years and older) with diabetes. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are required for calibration one time a week after day 13, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense 365 CGM System is a prescription device; patients should talk to their health care provider to learn more.
For important safety information, see bit.ly/eversensesafety
Eversense, Eversense E3 Continuous Glucose Monitoring, Eversense 365 Continuous Glucose Monitoring, and the Eversense logo are trademarks of Senseonics, Incorporated. Ascensia, the Ascensia Diabetes Care logo are trademarks and/or registered trademarks of Ascensia Diabetes Care Holdings AG. All other trademarks are properties of their respective owners and are used solely for informative purposes. No relationship or endorsement should be inferred or implied.
Apple Watch® is a product of Apple, Inc., and may be separately purchased from an authorized Apple retailer. Apple Watch is not included with the Eversense CGM System. Android is a trademark of Google LLC.